KR960030940A - 개선된 백금 착체 - Google Patents
개선된 백금 착체 Download PDFInfo
- Publication number
- KR960030940A KR960030940A KR1019960003292A KR19960003292A KR960030940A KR 960030940 A KR960030940 A KR 960030940A KR 1019960003292 A KR1019960003292 A KR 1019960003292A KR 19960003292 A KR19960003292 A KR 19960003292A KR 960030940 A KR960030940 A KR 960030940A
- Authority
- KR
- South Korea
- Prior art keywords
- platinum
- carboxylate
- complex
- substituted
- hydroxy
- Prior art date
Links
- 150000003057 platinum Chemical class 0.000 title abstract 2
- 150000001412 amines Chemical class 0.000 claims abstract 4
- 125000005843 halogen group Chemical group 0.000 claims abstract 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract 3
- -1 carbonate ester Chemical class 0.000 claims abstract 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims abstract 3
- 150000007942 carboxylates Chemical class 0.000 claims abstract 3
- 229910052697 platinum Inorganic materials 0.000 claims abstract 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims abstract 3
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims abstract 2
- 108020004414 DNA Proteins 0.000 claims abstract 2
- 102000053602 DNA Human genes 0.000 claims abstract 2
- 206010028980 Neoplasm Diseases 0.000 claims abstract 2
- 125000004429 atom Chemical group 0.000 claims abstract 2
- 201000011510 cancer Diseases 0.000 claims abstract 2
- 125000001424 substituent group Chemical group 0.000 claims abstract 2
- 210000004881 tumor cell Anatomy 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- IWBFMNLPFLCMBG-UHFFFAOYSA-N 2-methylpyridine;platinum Chemical compound [Pt].CC1=CC=CC=N1 IWBFMNLPFLCMBG-UHFFFAOYSA-N 0.000 claims 1
- OHTGBYRPUSAANG-UHFFFAOYSA-N [Pt].CC1=NC(=CC=C1)C Chemical compound [Pt].CC1=NC(=CC=C1)C OHTGBYRPUSAANG-UHFFFAOYSA-N 0.000 claims 1
- BNZSQNHMCVRXBB-UHFFFAOYSA-N [Pt].CC1=NC=CC(=C1)C Chemical compound [Pt].CC1=NC=CC(=C1)C BNZSQNHMCVRXBB-UHFFFAOYSA-N 0.000 claims 1
- LIPPGHVACMTZIG-UHFFFAOYSA-N [Pt].ClC1=C(C(=NC2=CC=CC=C12)C)Cl Chemical compound [Pt].ClC1=C(C(=NC2=CC=CC=C12)C)Cl LIPPGHVACMTZIG-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 125000002950 monocyclic group Chemical group 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 150000003222 pyridines Chemical class 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 230000031018 biological processes and functions Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- XKHCXFBIZREUJD-UHFFFAOYSA-N chloro hydrogen carbonate Chemical compound OC(=O)OCl XKHCXFBIZREUJD-UHFFFAOYSA-N 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Photolithography (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Studio Devices (AREA)
Abstract
다음 식 (Ia) 또는 (Ib)
[식에서 각 A는 이탈기이며 동일 또는 상이할 수 있고, 적당하게는 할로, 특히 클로로, 히드록시, 카르복실레이트이거나 또는 함께 두자리(bi-dentate) 카르복실레이트 또는 술페이트를 형성하고, 동일 또는 상이할 수 있는 각 B는 할로, 히드록시, 카르복실레이트, 카르바메이트 또는 카르보네이트 에스테르이고 Z는 치환기가 종양세포의 DNA 가닥에의 Pt원자의 접근을 입체적으로 장애하는 치환아민이고, X는 NH3또는 모노- 또는 디- 알킬 치환 NH3이다.]의 백금 착체는 암세포에 대해 활성이며 독특한 형태의 화학적 및 생물학적 작용을 나타내는 것으로 보인다.
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (11)
- 다음 일반식 (Ia) 또는 (Ib)의 cis-백금 착체.[식에서 각 A는 이탈기며 동일 또는 상이할 수 있거나 또는 함께 두자리 카르복실레이트 또는 술페이트를 형성하고, 동일 또는 상이할 수 있는 각 B는 할로, 히드록시, 카르복실레이트, 카르바메이트 또는 카르보네이트 에스테르이고, Z는 치환기가 종양 세포의 DNA 가닥에의 Pt원자의 접근을 입체적으로 장애하는 치환 아민이고, X는 NH3또는 모노- 또는 디- 알킬 치환 NH3이다.]
- 제1항에 있어서, Z는 5 또는 6원 단일고리형 또는 8 내지 10원 여러고리형 아민인 것을 특징으로 하는 착체.
- 제3항에 있어서, Z는 치환 피리딘 또는 아민이 피리딘고리의 질소원자를 통해 배위된 두고리형 아민인 것을 특징으로 하는 착체.
- 제3항에 있어서, Z는 2위치에서 저급 알킬 또는 알콕시로 치환되어 있는 것을 특징으로 하는 착체.
- 제1항 내지 제4항 중 어느 한 항에 있어서, 각 A는 할로, 히드록시, 카르복실레이트이거나 또는 함께 두자리 카르복실레이트 또는 술페이트를 형성하는 것을 특징으로 하는 착체.
- 제1항에 있어서, (SP-4-3)-암민디클로로 (2-메틸피리딘) 백금(Ⅱ), (SP-4-3)-암민디클로로(2-에틸피리딘) 백금(Ⅱ), (SP-4-3)-암민디클로로 (2-메틸퀴놀린) 백금(Ⅱ), (SP-4-3)-암민디클로로(2,4-디메틸피리딘) 백금(Ⅱ), (SP-4-3)-암민디클로로 (2-이소프로필피리딘)백금(Ⅱ), (SP-4-3)-암민디클로로 (2,6-디메틸피리딘)백금(Ⅱ), (OC-6-43)-암민디클로로디히드록소(2,4-디메틸피리딘) 백금(Ⅳ), (OC-6-43)-암민비스부티레이토디클로로 (2,4-디메틸피리딘) 백금(Ⅳ), 및 암민(시클로부탄-1, 1-디카르복실레이트)(2,4-디메틸피리딘) 백금(Ⅱ)로부터 선택되는 것을 특징으로 하는 착제.
- 제1항 내지 제6항 중 어느 한 항에 따른 착체를 유효성분으로 하여 약학적으로 허용되는 회석제 또는 담체 및 임의로 한가지 이상의 다른 치료제와 혼합하여 이루어지는 의약 조성물.
- 제7항에 있어서, 단위 투여량 형태인 것을 특징으로 하는 조성물.
- 제7항 또는 제8항에 있어서, 경구 투여용인 것을 특징으로 하는 조성물.
- 제1항 내지 제6항 중 어느 한 항에 있어서, 의약품용인 것을 특징으로 하는 착체.
- 암 치료용 의약의 제조에서의 제1항 내지 제6항 중 어느 한 항에 따른 착체의 사용.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9502799.1A GB9502799D0 (en) | 1995-02-14 | 1995-02-14 | Improvements in platinum complexes |
GB9502799.1 | 1995-02-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR960030940A true KR960030940A (ko) | 1996-09-17 |
KR100339866B1 KR100339866B1 (ko) | 2002-11-07 |
Family
ID=10769529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960003292A KR100339866B1 (ko) | 1995-02-14 | 1996-02-12 | 개선된백금착체 |
Country Status (19)
Country | Link |
---|---|
US (2) | US5665771A (ko) |
EP (1) | EP0727430B1 (ko) |
JP (1) | JP3219235B2 (ko) |
KR (1) | KR100339866B1 (ko) |
AT (1) | ATE202111T1 (ko) |
AU (1) | AU707814B2 (ko) |
CA (1) | CA2169019C (ko) |
DE (1) | DE69613254T2 (ko) |
DK (1) | DK0727430T3 (ko) |
ES (1) | ES2157399T3 (ko) |
FI (1) | FI120493B (ko) |
GB (1) | GB9502799D0 (ko) |
GR (1) | GR3036513T3 (ko) |
HK (1) | HK1011997A1 (ko) |
NO (1) | NO307569B1 (ko) |
NZ (1) | NZ280946A (ko) |
PT (1) | PT727430E (ko) |
TW (1) | TW432068B (ko) |
ZA (1) | ZA96885B (ko) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001872A (en) * | 1999-03-05 | 1999-12-14 | Virginia Commonwealth University | Water soluble transplatinum complexes with anti-cancer activity and method of using same |
US6518428B1 (en) * | 1999-04-13 | 2003-02-11 | Anormed, Inc. | Process for preparing amine platinum complexes |
US6413953B1 (en) * | 1999-04-13 | 2002-07-02 | Anormed Inc. | Pt(IV) antitumor agent |
AU775373B2 (en) | 1999-10-01 | 2004-07-29 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
AUPQ641100A0 (en) * | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
US6894049B1 (en) * | 2000-10-04 | 2005-05-17 | Anormed, Inc. | Platinum complexes as antitumor agents |
CA2456348A1 (en) * | 2001-08-23 | 2003-03-06 | Yechezkel Barenholz | Platinum complexes and their uses in therapy |
WO2007021852A2 (en) * | 2005-08-11 | 2007-02-22 | Virginia Commonwealth University | Transplatinum complexes with n2o2 donor sets as cytotoxic and antitumor agents |
US8168661B2 (en) * | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8173686B2 (en) * | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
US8178564B2 (en) * | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
RU2009133446A (ru) * | 2007-02-09 | 2011-03-20 | Пониард Фармасьютикалз, Инк. (Us) | Стабилизированная дозированная форма пикоплатина для перорального применения |
US20110033528A1 (en) * | 2009-08-05 | 2011-02-10 | Poniard Pharmaceuticals, Inc. | Stabilized picoplatin oral dosage form |
AU2008214199A1 (en) * | 2007-02-09 | 2008-08-14 | Poniard Pharmaceuticals, Inc. | Encapsulated picoplatin |
TW200916094A (en) * | 2007-06-27 | 2009-04-16 | Poniard Pharmaceuticals Inc | Stabilized picoplatin dosage form |
US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
JP2010533714A (ja) * | 2007-07-16 | 2010-10-28 | ポニアード ファーマシューティカルズ, インコーポレイテッド | ピコプラチンのための経口製剤 |
JP2011511072A (ja) * | 2008-02-08 | 2011-04-07 | ポニアード ファーマシューティカルズ, インコーポレイテッド | 結腸直腸癌を治療するためのピコプラチンおよびベバシツマブの使用 |
CN101775040B (zh) * | 2009-12-31 | 2012-05-09 | 南京臣功制药有限公司 | 吡铂的制备方法 |
US9771387B2 (en) | 2013-07-16 | 2017-09-26 | Placon Therapeutics | Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof |
CN106943343B (zh) * | 2016-01-06 | 2020-05-12 | 山东新时代药业有限公司 | 一种甲啶铂注射液及其制备方法 |
WO2017192290A1 (en) | 2016-05-04 | 2017-11-09 | The Wistar Institute Of Anatomy And Biology | Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and platinum-based antineoplastic drugs |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1432562A (en) | 1972-04-10 | 1976-04-22 | Rustenburg Platinum Mines Ltd | Platinum co-ordination compounds |
KR840007599A (ko) * | 1983-01-21 | 1984-12-08 | 마쓰바라 이찌로오 | 백금 착화합 유기물의 제조방법 |
US4533502A (en) * | 1983-02-22 | 1985-08-06 | Rochon Fernande D | Platinum (II) compounds and their preparation |
EP0167310B1 (en) * | 1984-06-27 | 1991-05-29 | Johnson Matthey Public Limited Company | Platinum co-ordination compounds |
JPS61238795A (ja) * | 1985-04-16 | 1986-10-24 | エンゲルハード・コーポレーシヨン | 白金トリアミン抗腫瘍剤 |
EP0273315B1 (en) * | 1986-12-18 | 1992-03-18 | SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. | Ammine-n-heterocyclic-platinum complexes and antitumor agents |
US4812193A (en) * | 1986-12-22 | 1989-03-14 | Gauron Richard F | Inset panel fastener and method of using |
DE68918878T2 (de) * | 1988-02-02 | 1995-02-23 | Johnson Matthey Inc | Pt(IV) Komplexe. |
GB8806044D0 (en) * | 1988-03-14 | 1988-04-13 | Johnson Matthey Plc | Platinum coordination compounds |
GB9105037D0 (en) * | 1991-03-09 | 1991-04-24 | Johnson Matthey Plc | Improvements in chemical compounds |
US5624919A (en) * | 1993-09-14 | 1997-04-29 | The University Of Vermont And State Agricultural College | Trans platinum (IV) complexes |
GB9408218D0 (en) * | 1994-04-26 | 1994-06-15 | Johnson Matthey Plc | Improvements in platinum complexes |
US6518428B1 (en) * | 1999-04-13 | 2003-02-11 | Anormed, Inc. | Process for preparing amine platinum complexes |
CA2456348A1 (en) * | 2001-08-23 | 2003-03-06 | Yechezkel Barenholz | Platinum complexes and their uses in therapy |
ES2327346T3 (es) * | 2004-09-01 | 2009-10-28 | Platco Technologies (Proprietary) Limited | Preparacion de complejos de platino (ii). |
WO2007021852A2 (en) * | 2005-08-11 | 2007-02-22 | Virginia Commonwealth University | Transplatinum complexes with n2o2 donor sets as cytotoxic and antitumor agents |
-
1995
- 1995-02-14 GB GBGB9502799.1A patent/GB9502799D0/en active Pending
-
1996
- 1996-01-29 DE DE69613254T patent/DE69613254T2/de not_active Expired - Lifetime
- 1996-01-29 EP EP96300601A patent/EP0727430B1/en not_active Expired - Lifetime
- 1996-01-29 AT AT96300601T patent/ATE202111T1/de active
- 1996-01-29 PT PT96300601T patent/PT727430E/pt unknown
- 1996-01-29 DK DK96300601T patent/DK0727430T3/da active
- 1996-01-29 ES ES96300601T patent/ES2157399T3/es not_active Expired - Lifetime
- 1996-01-31 AU AU42258/96A patent/AU707814B2/en not_active Expired
- 1996-02-05 ZA ZA96885A patent/ZA96885B/xx unknown
- 1996-02-07 TW TW085101525A patent/TW432068B/zh not_active IP Right Cessation
- 1996-02-07 CA CA002169019A patent/CA2169019C/en not_active Expired - Lifetime
- 1996-02-07 NZ NZ280946A patent/NZ280946A/en not_active IP Right Cessation
- 1996-02-07 US US08/597,953 patent/US5665771A/en not_active Ceased
- 1996-02-12 KR KR1019960003292A patent/KR100339866B1/ko not_active IP Right Cessation
- 1996-02-13 NO NO960569A patent/NO307569B1/no not_active IP Right Cessation
- 1996-02-14 FI FI960660A patent/FI120493B/fi not_active IP Right Cessation
- 1996-02-14 JP JP02693596A patent/JP3219235B2/ja not_active Expired - Lifetime
-
1998
- 1998-12-10 HK HK98113066A patent/HK1011997A1/xx not_active IP Right Cessation
-
2001
- 2001-09-04 GR GR20010401373T patent/GR3036513T3/el unknown
-
2009
- 2009-05-08 US US12/437,889 patent/USRE41209E1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FI960660A (fi) | 1996-08-15 |
FI960660A0 (fi) | 1996-02-14 |
GR3036513T3 (en) | 2001-12-31 |
NO307569B1 (no) | 2000-04-25 |
NO960569D0 (no) | 1996-02-13 |
DE69613254T2 (de) | 2001-09-20 |
DE69613254D1 (de) | 2001-07-19 |
GB9502799D0 (en) | 1995-04-05 |
ES2157399T3 (es) | 2001-08-16 |
AU707814B2 (en) | 1999-07-22 |
FI120493B (fi) | 2009-11-13 |
CA2169019A1 (en) | 1996-08-15 |
AU4225896A (en) | 1996-08-22 |
DK0727430T3 (da) | 2001-09-03 |
EP0727430A1 (en) | 1996-08-21 |
PT727430E (pt) | 2001-11-30 |
ATE202111T1 (de) | 2001-06-15 |
HK1011997A1 (en) | 1999-07-23 |
US5665771A (en) | 1997-09-09 |
NZ280946A (en) | 1997-05-26 |
KR100339866B1 (ko) | 2002-11-07 |
CA2169019C (en) | 2003-02-04 |
JP3219235B2 (ja) | 2001-10-15 |
EP0727430B1 (en) | 2001-06-13 |
NO960569L (no) | 1996-08-15 |
JPH08259581A (ja) | 1996-10-08 |
TW432068B (en) | 2001-05-01 |
USRE41209E1 (en) | 2010-04-06 |
ZA96885B (en) | 1996-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR960030940A (ko) | 개선된 백금 착체 | |
GEP20033140B (en) | Substituted Bicyclic Derivatives Useful as Anticancer Agents | |
ATE224888T1 (de) | Pyridylalken- und pyridylalkin-säureamide als cytostatika und immunosuppressive arzneimittel | |
FI952607A (fi) | Farmakologisesti aktiiviset pyridiinijohdannaiset ja menetelmät niiden valmistamiseksi | |
GEP20033025B (en) | 4,4-Biarylpiperidine Derivatives with Opioid Receptor Activity | |
UA70942C2 (uk) | Застосування n-заміщеного індоліл-3-гліоксиламіду як протипухлинного засобу, спосіб лікування пухлинних захворювань та лікарська композиція для лікування пухлинних захворювань | |
ATE386808T1 (de) | Arzneimittelzubereitungen für die behandlung von alpha-galactosidase a-mangel | |
AU5270500A (en) | Macromolecular carrier for drug and diagnostic agent delivery | |
GEP20033001B (en) | Alkynyl-Substituted Quinolin-2-One Derivatives Useful As Anticancer Agents | |
ATE289602T1 (de) | Quinolin-2-on-derivate verwendbar als antikrebsmittel | |
CS145091A3 (en) | Isoxazole-4-carboxamides and amides of hydroxyalkylidene cyanacetic acid, medicaments comprising said compounds and their application | |
IL144026A0 (en) | Phenylphenanthridine derivatives and pharmaceutical compostions containing the same | |
MX9702382A (es) | Nuevos derivados de pirimidona con actividad antifungica. | |
DE60134245D1 (de) | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten | |
TR200200226T2 (tr) | Karbonasitamidler, bu bileşikleri ihtiva eden ilaç, kullanımı ve üretimi. | |
TR200103683T2 (tr) | Indol türevleri ve bu türevlerin diğer uygulamaların yanısıra osteoporoz tedavisinde kullanımı | |
BG104436A (en) | The administration of macrolides for the treatment of cancer and macular degeneration | |
UA42733C2 (uk) | Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить | |
CA2145585A1 (en) | N-oxides and derivatives of chlorambucil for treating hypoxic tumor cells | |
MX9601635A (es) | Derivados de antraciclina. | |
ATE363909T1 (de) | Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten | |
BG106180A (en) | Pharmaceutical composition containing sibutramine and orlistat | |
GB1391862A (en) | Benzodiazepines | |
KR870003098A (ko) | 치환된 3-(4-페닐-1-피페라지닐)알킬퀴나졸린-2,4-(1h,3h)디온의 제조방법 | |
YU25202A (sh) | Supstituisani piroli kao antiproliferativna sredstva za lečenje kancera |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130502 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20140508 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20150430 Year of fee payment: 14 |
|
EXPY | Expiration of term |